Skip to main content
Clinical Trials/NCT02074033
NCT02074033
Unknown
Not Applicable

Determination of Errors in Prescription Antibiotics in Ventilator-associated Pneumonia in Unit of Intensive Care of Clinical Hospital of Federal University of Uberlandia - Brazil

Federal University of Uberlandia1 site in 1 country130 target enrollmentMarch 2014
ConditionsPneumonia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pneumonia
Sponsor
Federal University of Uberlandia
Enrollment
130
Locations
1
Primary Endpoint
Determination of Errors in Prescription Antibiotics in Ventilator-associated Pneumonia in Unit of Intensive Care of Clinical Hospital of Federal University of Uberlandia - Brazil
Last Updated
12 years ago

Overview

Brief Summary

The infection is a major risk to hospitalized patients, especially those admitted to the Intensive Care Unit (ICU) and an unfavorable factor in the outcome of critically ill patients, increasing costs and prolonging hospitalization hospitalar. The ventilator-associated pneumonia (PAV) is considered the most prevalent nosocomial infection in the ICU, occurring in 9% to 68% of patients with prosthetic ventilatória.Due to the high rate of PAV and mortality related to it, is very important both prescription and administration of antibiotics correctly, as deescalation or escalation according the result of cultures.Therefore, the objectives of this study is assess if whether the antibiotic prescribed of ventilator-associated pneumonia following the orientation of literature. Will also be assessed the rate of PAV in patients critically ill adults, the main microorganisms responsible by PAV and determining antimicrobial susceptibility.

Detailed Description

In patients who had a diagnosis of ventilator-associated pneumonia by asssistente physician will be assessed initially prescribed antibiotics empirically and what conduct adopted after culture results. We will be examined whether the antibiotic prescribed following the orientation of literature, considering the dose, interval between doses, dose adjustment for renal failure infusion time, treatment time and conduct after the culture results (deescalation, escalation or maintenance of antimicrobial initially prescribed ) . The deescalation consists of discontinuing the use of antimicrobial or antibiotic change to another with lower coverage and spectrum is performed, escalation occurs when adding a new antibiotic or antibiotic to change the coverage of other larger spectrum after culture results .

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
October 2014
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Federal University of Uberlandia
Responsible Party
Principal Investigator
Principal Investigator

Ana Carolina Souza Oliveira

graduate student

Federal University of Uberlandia

Eligibility Criteria

Inclusion Criteria

  • Be 18 years of age;
  • Having the diagnosis of ventilator-associated pneumonia.

Exclusion Criteria

  • Be under 18 years of age;

Outcomes

Primary Outcomes

Determination of Errors in Prescription Antibiotics in Ventilator-associated Pneumonia in Unit of Intensive Care of Clinical Hospital of Federal University of Uberlandia - Brazil

Time Frame: six months

Study Sites (1)

Loading locations...

Similar Trials